Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Gordon

Showing results (41-50 of 327) with videos related to

Pageof 33
Sort By:
Clinical and Experimental Pharmacology & Physiology|May 1, 1991
Clonidine suppression test reliably differentiates phaeochromocytoma from essential hypertensionA W Bachmann, R D Gordon
International Journal of Chronobiology|January 1, 1973
Time related aspects of arterial blood pressure, plasma volume, and electrolyte homeostasis in manR D Gordon, R H Mortimer
Scottish Medical Journal|January 1, 1986
The syndrome of hypertension and hyperkalaemia without renal failure: long term correction by thiazide diureticR D Gordon, G P Hodsman
European Journal of Biochemistry|October 20, 1989
Synthesis and characterization of mu-conotoxin IIIaS Becker, E Atherton, R D Gordon
Gastroenterology Clinics of North America|March 1, 1988
A liver transplant center information management systemR D Gordon, B Markus, S Mitchell
FEBS Letters|October 15, 1990
Synthesis and characterization of an N-terminal-specific 125I-photoaffinity derivative of mu-Conotoxin GIIIA which binds to the voltage-dependent sodium channelS Becker, R Liebe, R D Gordon
Journal of Human Hypertension|July 13, 2012
Salt, aldosterone and hypertensionE Pimenta, R D Gordon, M Stowasser
Australian and New Zealand Journal of Medicine|March 4, 1998
A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type IM Stowasser, M G Gartside, R D Gordon
Pathology|July 1, 1983
Factors affecting the frequency of occurrence of spironolactone bodies in aldosteronomas and non-tumorous cortexD Cohn, R V Jackson, R D Gordon
Clinical and Experimental Pharmacology & Physiology|March 21, 2002
Familial varieties of primary aldosteronismM Stowasser, T G Gunasekera, R D Gordon
Pageof 33

Showing results (41-50 of 327) with videos related to

Sort By:
Pageof 33
Clinical and Experimental Pharmacology & Physiology|May 1, 1991
Clonidine suppression test reliably differentiates phaeochromocytoma from essential hypertensionA W Bachmann, R D Gordon
International Journal of Chronobiology|January 1, 1973
Time related aspects of arterial blood pressure, plasma volume, and electrolyte homeostasis in manR D Gordon, R H Mortimer
Scottish Medical Journal|January 1, 1986
The syndrome of hypertension and hyperkalaemia without renal failure: long term correction by thiazide diureticR D Gordon, G P Hodsman
European Journal of Biochemistry|October 20, 1989
Synthesis and characterization of mu-conotoxin IIIaS Becker, E Atherton, R D Gordon
Gastroenterology Clinics of North America|March 1, 1988
A liver transplant center information management systemR D Gordon, B Markus, S Mitchell
FEBS Letters|October 15, 1990
Synthesis and characterization of an N-terminal-specific 125I-photoaffinity derivative of mu-Conotoxin GIIIA which binds to the voltage-dependent sodium channelS Becker, R Liebe, R D Gordon
Journal of Human Hypertension|July 13, 2012
Salt, aldosterone and hypertensionE Pimenta, R D Gordon, M Stowasser
Australian and New Zealand Journal of Medicine|March 4, 1998
A PCR-based method of screening individuals of all ages, from neonates to the elderly, for familial hyperaldosteronism type IM Stowasser, M G Gartside, R D Gordon
Pathology|July 1, 1983
Factors affecting the frequency of occurrence of spironolactone bodies in aldosteronomas and non-tumorous cortexD Cohn, R V Jackson, R D Gordon
Clinical and Experimental Pharmacology & Physiology|March 21, 2002
Familial varieties of primary aldosteronismM Stowasser, T G Gunasekera, R D Gordon
Pageof 33